KL2-Mentored Clinical and Translational Research Scholars Program
The KL2 program provides the opportunity to build upon the resources of the Georgia CTSA and other established programs in supporting junior faculty members who want to establish a successful clinical and/or translational research career. The KL2 program provides the opportunity for didactic training (in large part through the MSCR or CPTR programs) and also requires that the trainee have an established and successful lead mentor (as well as an Advisory Committee) who could provide further guidance and training for those pursuing careers in clinical and/or translational investigation.
- KL2 Scholar Awarded K23 Award
- CTSI's KL2 Scholar and Yerkes Primate Research Center
- Former KL2 Scholar Serves as Deputy Director of the Satcher Health Leadership Institute & PI of a CDC REACH Award
- CTSI Trainee Receives CBPR R-Grant
- Science Advance: Transplant Decision App
- KL2 Scholar Publishes Newly Described Disease Case in NEJM
- CTSI Current KL2 Scholar Published in NEJM
- Scholars to Serve as Associate Scientific Advisors
- CTSI Scholar Links Severe Anemia to Intestinal Disease Risk in Premature Infants
- KL2 Scholar Studies Inflammation's Effects on Weakened Reward Circuits in Depression
- CTSI's I-Corps Leader
The KL2 program responds to national efforts to support the training and development of junior faculty members who will become well trained, successful, and independent clinical and/or translational investigators. The KL2 program builds on the considerable strengths and outstanding resources in Atlanta and at Emory, MSM, Georgia Tech, and UGA College of Pharmacy.
The Georgia CTSA KL2 addresses the recommendations of the National Academy of Medicine and others about the need to intensify efforts to train and retain clinical and translational researchers in order to reverse the dramatic decline of clinical and/or translational investigators entering the research workforce. The rationale for the education and training program includes the expanding need for high-quality clinical and translational research; the necessity for integration of the analytic sciences and clinical and translational research; the need to translate research findings from the bench to the bedside and from the bedside to the community; the importance of interdisciplinary education and training in clinical and translational research; and the extensive expertise in and record of clinical investigation represented by the faculty at the collaborating institutions (i.e., Emory, MSM, Georgia Tech, and UGA College of Pharmacy).
The MSCR or CPTR programs at either Emory or MSM provide didactic training for those applicants from the respective institutions accepted into the KL2 program. All applicants accepted into the Georgia CTSA KL2 program will be required to enroll in the MSCR program (either at Emory or MSM) or CPTR, although students can take courses in either program and there are some joint courses. The Emory MSCR program is offered by the James T. Laney School of Graduate Studies.
The Emory MSCR program requires a minimum of 30 hours of academic credit that include in-class didactic coursework and a written research thesis. Generally, three semesters of didactic study (10-12 months minimum for full-time students) are required and an optimal time of 18-24 months to complete the program (including the mentored thesis). For most investigators, the period of two years is appropriate to accomplish both the didactic work (one year) and completion of an appropriate investigative research thesis.
The MSM MSCR program is a broad-based multidisciplinary graduate level program in clinical and translational research designed to address the problem of health disparities and the shortage of clinical and translational researchers through a concerted effort to recruit and train doctoral prepared minority candidates for successful careers in clinical and translational research. The program provides training in the principles and methods of biostatistics, epidemiology, including genetics and clinical trials, big data and informatics, and outcomes research, including health services research, patient centered outcomes research methods and community engagement.